{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-22-011511","form_type":"8-K","ticker":"BLFS","cik":"0000834365","company_name":"BIOLIFE SOLUTIONS INC","filed_at":"2022-05-09T23:59:59+00:00","discovered_at":"2026-05-14T18:04:03.886406+00:00","generated_at":"2026-06-25T22:44:39.683878+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"BioLife Solutions Q1 revenue $36.2M (+115% YoY); net loss $7.1M vs $1.1M","bullets":["GAAP EPS -$0.17 vs -$0.03; adjusted EBITDA -$814K vs +$2.8M a year ago.","Organic revenue growth 45%; biopreservation media revenue up 53%.","Gross margin GAAP 29%, adjusted 33%; improved sequentially from Q4 2021.","FY22 revenue guidance reaffirmed $159.5-$171M (34-44% growth); expects positive adj. EBITDA.","Management & board to accept shares in lieu of cash compensation."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-22-011511","json":"https://secwatch.observer/filing/0001437749-22-011511.json","markdown":"https://secwatch.observer/filing/0001437749-22-011511.md","text":"https://secwatch.observer/filing/0001437749-22-011511.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/834365/000143774922011511/0001437749-22-011511-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/834365/000143774922011511/bioli20220509_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T22:44:39.683878+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}